Evaluation of two treatments in superovulation of mares.
Abstract: The efficiency of superovulating mares with an enriched fraction of equine follicle-stimulating hormone (feFSH) and an equine pituitary extract (EPE) with similar FSH content but differing in the LH amount was compared. Mares were randomly assigned to an feFSH (n = 5) or EPE (n = 5) treatment. The experimental period was of 2 successive estrous cycles, with the first cycle as the control. At Days 6 and 7 of the estrous cycle, the mares received 250 micrograms i.m. cloprostenol. The treatments consisted of daily injections of 25 mg feFSH or EPE beginning on Day 6 post ovulation. Mares were inseminated every other day until the last ovulation was detected. When the mares in the control and treatment cycles developed at least 1 or 2 > or = 35-mm follicle, respectively, the treatment was interrupted, and a single injection of EPE (25 mg, i.v.) was administered to induce ovulation(s). Nonsurgical embryo recovery was performed 6 or 7 d after ovulation in both control and treatment cycles. The number of ovulations per mare was not significantly different (P > 0.05) between feFSH and EPE groups, but both were higher (P 0.05) for control, feFSH and EPE groups. The high amount of LH presented in EPE did not affect the superovulatory response of the mares. Superovulatory treatments increased the ovulation rate of mares but did not affect the embryo recovery rate per ovulation.
Publication Date: 2000-03-25 PubMed ID: 10732063DOI: 10.1016/S0093-691X(98)00073-9Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Comparative Study
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research study aims to analyze the efficacy of two hormone treatments in stimulating the superovulation of mares. Despite disparities in luteinizing hormone (LH) content, no significant differences were noted between mares treated with enriched follicle-stimulating hormone (feFSH) and equine pituitary extract (EPE), though both treatments surpassed the control group in terms of ovulation rate. Unexpectedly, embryo recovery rate remained unimpacted by these treatments.
Study Design and Group Allocation
- The study was conducted over two consecutive estrous cycles, the initial cycle serving as control.
- Ten mares were arbitrarily split into two groups, each consisting of five mares. One group was administered with feFSH, and the other with EPE.
- Both treatments contained equal follicle-stimulating hormone (FSH) quantities but varied in the luteinizing hormone (LH) amount.
Treatment and Process
- From Day 6 following ovulation, mares received daily doses of either 25 mg feFSH or EPE treatment.
- These treatments were halted once the mares cultivated one or two follicles of at least 35mm in diameter in control and treatment cycles, respectively.
- Consequently, a one-time injection of 25 mg EPE was given to induce ovulation.
- Every second day, until the detection of the final ovulation, mares were inseminated.
- A week after ovulation, non-surgical embryo recovery was performed in both control and treatment cycles.
Results and Conclusion
- Statistical analysis determined no significant differences in mare ovulations between the feFSH and EPE treatment groups. However, both groups demonstrated higher ovulation rates than the control cycle.
- Interestingly, the amount of embryos retrieved per ovulation remained similar across the control, feFSH, and EPE groups, indicating that the superovulatory treatments did not impact this aspect.
- The high LH content in the EPE treatment was observed to not influence the superovulatory response of the mares.
- The study concludes that while superovulatory treatments can amplify the ovulation rate in mares, they may not necessarily affect the embryo recovery rate per ovulation.
Cite This Article
APA
Rosas CA, Alberio RH, Barañao JL, Agüero A, Chaves MG.
(2000).
Evaluation of two treatments in superovulation of mares.
Theriogenology, 49(7), 1257-1264.
https://doi.org/10.1016/S0093-691X(98)00073-9 Publication
Researcher Affiliations
- CENARGEN/EMBRAPA CP 02372 CEP 70.849-970 Brasília-DF, Brasil.
MeSH Terms
- Animals
- Cloprostenol / therapeutic use
- Estrus
- Female
- Fertilization in Vitro / veterinary
- Follicle Stimulating Hormone / analysis
- Follicle Stimulating Hormone / physiology
- Horses / physiology
- Luteinizing Hormone / analysis
- Luteinizing Hormone / physiology
- Male
- Ovarian Follicle / physiology
- Ovary / diagnostic imaging
- Photoperiod
- Pituitary Gland / chemistry
- Pituitary Gland / metabolism
- Radioligand Assay / veterinary
- Random Allocation
- Superovulation / physiology
- Ultrasonography
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
